Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |